Cardinal Health (CAH) Competitors $157.70 -0.20 (-0.13%) As of 10:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CAH vs. DXCM, HOLX, MMSI, AMN, COR, ELV, HAE, ITGR, MCK, and HSICShould you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include DexCom (DXCM), Hologic (HOLX), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), Elevance Health (ELV), Haemonetics (HAE), Integer (ITGR), McKesson (MCK), and Henry Schein (HSIC). These companies are all part of the "medical" sector. Cardinal Health vs. Its Competitors DexCom Hologic Merit Medical Systems AMN Healthcare Services Cencora Elevance Health Haemonetics Integer McKesson Henry Schein DexCom (NASDAQ:DXCM) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Do insiders and institutionals hold more shares of DXCM or CAH? 97.8% of DexCom shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.1% of Cardinal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, DXCM or CAH? Cardinal Health has higher revenue and earnings than DexCom. Cardinal Health is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDexCom$4.03B8.22$576.20M$1.3463.12Cardinal Health$226.83B0.17$852M$6.4124.60 Do analysts prefer DXCM or CAH? DexCom currently has a consensus target price of $99.21, suggesting a potential upside of 17.30%. Cardinal Health has a consensus target price of $158.07, suggesting a potential upside of 0.24%. Given DexCom's stronger consensus rating and higher possible upside, equities analysts plainly believe DexCom is more favorable than Cardinal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 2 Strong Buy rating(s) 2.90Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.79 Is DXCM or CAH more profitable? DexCom has a net margin of 12.90% compared to Cardinal Health's net margin of 0.70%. DexCom's return on equity of 30.05% beat Cardinal Health's return on equity.Company Net Margins Return on Equity Return on Assets DexCom12.90% 30.05% 10.00% Cardinal Health 0.70%-68.84%4.21% Which has more volatility and risk, DXCM or CAH? DexCom has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Does the media prefer DXCM or CAH? In the previous week, DexCom had 7 more articles in the media than Cardinal Health. MarketBeat recorded 36 mentions for DexCom and 29 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 1.46 beat DexCom's score of 1.10 indicating that Cardinal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 21 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardinal Health 22 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDexCom beats Cardinal Health on 13 of the 17 factors compared between the two stocks. Get Cardinal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAH vs. The Competition Export to ExcelMetricCardinal HealthMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$37.70B$15.20B$5.59B$20.76BDividend Yield1.30%1.44%4.71%3.61%P/E Ratio24.6417.7430.0328.75Price / Sales0.172.21448.3856.15Price / Cash14.9417.6036.0123.15Price / Book-11.963.648.424.56Net Income$852M$430.42M$3.25B$993.26M7 Day Performance-0.29%-5.95%-1.68%-1.77%1 Month Performance-6.09%-1.77%8.45%2.07%1 Year Performance56.42%14.31%36.65%7.58% Cardinal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAHCardinal Health4.8255 of 5 stars$157.70-0.1%$158.07+0.2%+57.6%$37.70B$226.83B24.6448,900Positive NewsDXCMDexCom4.7955 of 5 stars$89.53+0.6%$98.72+10.3%+27.8%$35.11B$4.03B66.8110,300Trending NewsEarnings ReportAnalyst ForecastInsider TradeHOLXHologic4.797 of 5 stars$65.62-1.3%$77.33+17.8%-21.2%$14.62B$4.03B27.697,063Trending NewsEarnings ReportMMSIMerit Medical Systems4.2843 of 5 stars$84.47-0.3%$109.11+29.2%-2.4%$4.99B$1.39B41.417,400News CoveragePositive NewsEarnings ReportAnalyst ForecastAMNAMN Healthcare Services4.3335 of 5 stars$19.71-0.5%$32.08+62.8%-72.7%$754.42M$2.98B-4.552,968CORCencora4.4534 of 5 stars$285.98-1.5%$309.83+8.3%+26.3%$55.43B$293.96B33.1846,000Positive NewsUpcoming EarningsELVElevance Health4.9287 of 5 stars$286.00-1.1%$418.19+46.2%-45.2%$64.40B$189.25B12.17104,200Positive NewsHAEHaemonetics4.9212 of 5 stars$74.66-0.7%$97.30+30.3%-14.5%$3.59B$1.36B22.563,023Positive NewsUpcoming EarningsITGRInteger3.3318 of 5 stars$108.02-0.5%$140.25+29.8%-10.2%$3.77B$1.79B47.5911,000Earnings ReportMCKMcKesson4.3294 of 5 stars$705.86-0.8%$710.17+0.6%+17.2%$88.31B$359.05B27.3345,000Positive NewsUpcoming EarningsDividend IncreaseHSICHenry Schein4.3389 of 5 stars$70.44-1.4%$78.08+10.9%-3.9%$8.57B$12.67B22.0125,000Upcoming Earnings Related Companies and Tools Related Companies DexCom Competitors Hologic Competitors Merit Medical Systems Competitors AMN Healthcare Services Competitors Cencora Competitors Elevance Health Competitors Haemonetics Competitors Integer Competitors McKesson Competitors Henry Schein Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CAH) was last updated on 7/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardinal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardinal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
